Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers

ABSTRACT

Histone posttranslational modifications control the organization and function of chromatin. In particular, methylation of lysine 36 in histone H3 (H3K36me) has been shown to mediate gene transcription, DNA repair, cell cycle regulation, and pre-mRNA splicing. Notably, mutations at or near this residue have been causally linked to the development of several human cancers. These observations have helped to illuminate the role of histones themselves in disease and to clarify the mechanisms by which they acquire oncogenic properties. This perspective focuses on recent advances in discovery and characterization of histone H3 mutations that impact H3K36 methylation. We also highlight findings that the common cancer-related substitution of H3K36 to methionine (H3K36M) disturbs functions of not only H3K36me-writing enzymes but also H3K36me-specific readers. The latter case suggests that the oncogenic effects could also be linked to the inability of readers to engage H3K36M.

KEYWORDS:

• Histone
• H3K36M
• cancer
• PTM
• methylation

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported in part by National Institute of General Medical Sciences [GM106416, GM101664 and GM100907 to T.G.K., and GM126900 to B.D.S.]. PWL is a Pew Scholar in the Biomedical Sciences.